MLAB
Mesa Laboratories Inc
137.50$
+3.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +18.0% | +11.7% | -19.0% | -49.5% | +249.8% | -31.3% | -85.1% | +334.3% | +128.1% | -25.6% | +5.5% | – | |
| – | +11.8% | -30.4% | -13.2% | +11.0% | -9.4% | +36.4% | -20.5% | -1.8% | -2.3% | -406.6% | – | – | |
| – | -6.0% | -6.7% | +4.9% | +31.0% | -15.6% | -3.1% | +23.7% | -1.8% | -11.3% | -427.5% | – | – | |
| – | – | – | -103.9% | – | +954.1% | +171.8% | -182.1% | – | – | -60.7% | -101.8% | – | |
| – | +77.9% | -52.6% | +66.5% | +100.7% | -54.5% | +23.9% | +0.2% | +8.2% | -33.0% | +287.0% | -80.3% | – | |
| – | +12,648.9% | – | -309.2% | +100.7% | -54.5% | +23.9% | +0.2% | +8.2% | -33.0% | -43.0% | +34.1% | – | |
| – | +0.0% | +0.2% | -0.1% | +0.3% | +0.3% | +0.1% | +0.3% | +1.0% | +0.2% | +0.0% | +0.0% | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +32.4% | +90.1% | – | -310.2% | +35.0% | +69.1% | -41.1% | – | |
| – | – | -121.3% | -29.6% | -5.5% | +23.1% | +52.8% | -48.0% | -6.5% | +24.1% | +61.1% | -33.4% | – | |
| – | -328.1% | – | – | -1,702.7% | – | -154.9% | – | – | – | -123.9% | – | – | |
| – | +13.8% | +18.7% | -22.7% | -63.5% | +406.1% | -33.9% | -92.4% | +706.6% | +152.8% | -6.8% | -15.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.